HALO
HealthcareHalozyme Therapeutics, Inc.
$63.74+0.18 (+0.28%)
Prev Close
$63.56
Open
$64.31
High
$64.58
Low
$63.22
Volume
741.2K
Market Cap
$7.99B
P/E
24.80
Div Yield
—
Over the past 12 months, insider activity at Halozyme Therapeutics, Inc. (HALO) has been exclusively selling, with 0 insider purchases totaling $0.00 and 22 insider sales totaling $45.55M. The most recent insider transaction was by Caudill Cortney (officer: SVP, CHIEF OPERATING OFFICER), who sold $1.96M worth of shares on Mar 10, 2026. Halozyme Therapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $7.99B.
Buys (12M)
0
$0.00
Sells (12M)
22
$45.55M
Net Activity
Net Seller
$45.55M
Active Insiders
6
last 12 mo
HALO Price Chart
HALO Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 10, 2026↗ | Caudill Cortney | officer: SVP, CHIEF OPERATING OFFICER | Sell | 28,857 | $67.75 | $1.96M | 16,466 |
| Mar 4, 2026↗ | Torley Helen | director, officer: PRESIDENT AND CEO | Sell | 100,000 | $69.52 | $6.95M | 783,680 |
| Feb 17, 2026↗ | Torley Helen | PRESIDENT AND CEO | Sell | 48,043 | $79.44 | $3.82M | 0 |
| Feb 16, 2026↗ | LaBrosse Nicole | SVP, CHIEF FINANCIAL OFFICER | Sell | 12,894 | $79.44 | $1.02M | 0 |
| Feb 16, 2026↗ | Snyder Mark Howard | SVP, CHIEF LEGAL OFFICER | Sell | 9,068 | $79.44 | $720.4K | 0 |
| Feb 5, 2026↗ | Torley Helen | director, officer: PRESIDENT AND CEO | Sell | 50,000 | $77.07 | $3.85M | 726,168 |
| Jan 6, 2026↗ | Connaughton Bernadette | director | Sell | 2,000 | $70.25 | $140.5K | 40,123 |
| Dec 1, 2025↗ | Connaughton Bernadette | Director | Sell | 829 | $71.60 | $59.4K | 42,123 |
| Dec 1, 2025↗ | Torley Helen | PRESIDENT AND CEO | Sell | 16,569 | $68.92 | $1.14M | 714,882 |
| Nov 12, 2025↗ | Connaughton Bernadette | Director | Sell | 2,000 | $68.48 | $137.0K | 42,952 |
| Nov 12, 2025↗ | Torley Helen | PRESIDENT AND CEO | Sell | 60,000 | $69.47 | $4.17M | 749,219 |
| Oct 3, 2025↗ | Torley Helen | PRESIDENT AND CEO | Sell | 60,000 | $71.86 | $4.31M | 747,119 |
| Oct 1, 2025↗ | Connaughton Bernadette | Sell | 2,000 | $75.24 | $150.5K | 45,452 | |
| Sep 23, 2025↗ | LaBrosse Nicole | SVP, CHIEF FINANCIAL OFFICER | Sell | 2,227 | $77.95 | $173.6K | 22,393 |
| Sep 11, 2025↗ | LaBrosse Nicole | SVP, CHIEF FINANCIAL OFFICER | Sell | 20,000 | $75.71 | $1.51M | 37,546 |
| Sep 4, 2025↗ | Torley Helen | PRESIDENT AND CEO | Sell | 60,000 | $74.08 | $4.44M | 753,419 |
| Sep 2, 2025↗ | Connaughton Bernadette | Sell | 4,000 | $73.68 | $294.7K | 50,852 | |
| Aug 13, 2025↗ | Torley Helen | PRESIDENT AND CEO | Sell | 60,000 | $63.62 | $3.82M | 740,677 |
| Jul 10, 2025↗ | Torley Helen | PRESIDENT AND CEO | Sell | 60,000 | $56.46 | $3.39M | 750,121 |
| Jun 24, 2025↗ | Torley Helen | PRESIDENT AND CEO | Sell | 60,000 | $53.09 | $3.19M | 749,230 |
| Apr 28, 2025↗ | Henderson Jeffrey William | Sell | 4,497 | $60.37 | $271.5K | 28,811 | |
| Apr 1, 2025↗ | Henderson Jeffrey William | Sell | 503 | $64.05 | $32.2K | 33,108 | |
| Mar 3, 2025↗ | Henderson Jeffrey William | Sell | 5,000 | $58.69 | $293.5K | 36,816 | |
| Feb 27, 2025↗ | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Sell | 21,697 | $58.10 | $1.26M | 186,153 |
| Feb 4, 2025↗ | Henderson Jeffrey William | Sell | 5,000 | $56.30 | $281.5K | 42,511 | |
| Jan 7, 2025↗ | Henderson Jeffrey William | Sell | 10,000 | $50.01 | $500.1K | 43,611 | |
| Oct 16, 2024↗ | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Sell | 20,000 | $53.50 | $1.07M | 173,833 |
| Oct 9, 2024↗ | Torley Helen | PRESIDENT AND CEO | Sell | 20,000 | $53.29 | $1.07M | 680,763 |
| Sep 26, 2024↗ | Torley Helen | PRESIDENT AND CEO | Sell | 30,000 | $56.88 | $1.71M | 676,744 |
| Sep 18, 2024↗ | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Sell | 20,000 | $62.46 | $1.25M | 175,793 |
| Sep 12, 2024↗ | Torley Helen | PRESIDENT AND CEO | Sell | 30,000 | $59.13 | $1.77M | 676,744 |
| Aug 21, 2024↗ | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Sell | 20,000 | $61.40 | $1.23M | 168,276 |
| Aug 15, 2024↗ | Torley Helen | PRESIDENT AND CEO | Sell | 30,000 | $57.15 | $1.71M | 683,481 |
| Aug 14, 2024↗ | Posard Matthew L. | Sell | 29,881 | $56.53 | $1.69M | 89,755 | |
| Jul 24, 2024↗ | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Sell | 20,000 | $55.00 | $1.10M | 173,467 |
| Jul 23, 2024↗ | LaBrosse Nicole | SVP, CHIEF FINANCIAL OFFICER | Sell | 5,000 | $53.93 | $269.7K | 15,480 |
| Jun 28, 2024↗ | LaBrosse Nicole | SVP, CHIEF FINANCIAL OFFICER | Sell | 30,000 | $51.93 | $1.56M | 15,480 |
| Jun 20, 2024↗ | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Sell | 10,000 | $49.43 | $494.3K | 168,176 |
| Jun 13, 2024↗ | Posard Matthew L. | Sell | 20,000 | $50.32 | $1.01M | 109,755 | |
| May 22, 2024↗ | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Sell | 20,000 | $45.27 | $905.5K | 168,176 |
| Apr 17, 2024↗ | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Sell | 20,000 | $38.42 | $768.4K | 168,176 |
| Mar 13, 2024↗ | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Sell | 20,000 | $41.96 | $839.1K | 156,558 |
| Feb 28, 2024↗ | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Sell | 20,000 | $39.75 | $794.9K | 159,087 |
| Jan 18, 2024↗ | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Sell | 20,000 | $36.00 | $720.0K | 151,911 |
| Dec 13, 2023↗ | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Sell | 20,000 | $40.01 | $800.3K | 152,554 |
| Nov 16, 2023↗ | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Sell | 20,000 | $39.43 | $788.7K | 151,911 |
| Oct 17, 2023↗ | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Sell | 10,000 | $36.52 | $365.2K | 151,911 |
| Sep 19, 2023↗ | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Sell | 10,000 | $39.10 | $391.0K | 151,911 |
| Aug 31, 2023↗ | Torley Helen | PRESIDENT AND CEO | Sell | 30,000 | $42.69 | $1.28M | 623,666 |
| Aug 23, 2023↗ | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Sell | 10,000 | $42.41 | $424.1K | 151,911 |
Showing 1–50 of 89
1 / 2
HALO Insider Buying Activity
The following table shows recent insider purchases of Halozyme Therapeutics, Inc. (HALO) stock reported via SEC Form 4 filings.
No insider buying activity found for HALO in the last 12 months.
HALO Insider Selling Activity
The following table shows recent insider sales of Halozyme Therapeutics, Inc. (HALO) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 10, 2026↗ | Caudill Cortney | officer: SVP, CHIEF OPERATING OFFICER | Sell | 28,857 | $67.75 | $1.96M | 16,466 |
| Mar 4, 2026↗ | Torley Helen | director, officer: PRESIDENT AND CEO | Sell | 100,000 | $69.52 | $6.95M | 783,680 |
| Feb 17, 2026↗ | Torley Helen | PRESIDENT AND CEO | Sell | 48,043 | $79.44 | $3.82M | 0 |
| Feb 16, 2026↗ | LaBrosse Nicole | SVP, CHIEF FINANCIAL OFFICER | Sell | 12,894 | $79.44 | $1.02M | 0 |
| Feb 16, 2026↗ | Snyder Mark Howard | SVP, CHIEF LEGAL OFFICER | Sell | 9,068 | $79.44 | $720.4K | 0 |
| Feb 5, 2026↗ | Torley Helen | director, officer: PRESIDENT AND CEO | Sell | 50,000 | $77.07 | $3.85M | 726,168 |
| Jan 6, 2026↗ | Connaughton Bernadette | director | Sell | 2,000 | $70.25 | $140.5K | 40,123 |
| Dec 1, 2025↗ | Connaughton Bernadette | Director | Sell | 829 | $71.60 | $59.4K | 42,123 |
| Dec 1, 2025↗ | Torley Helen | PRESIDENT AND CEO | Sell | 16,569 | $68.92 | $1.14M | 714,882 |
| Nov 12, 2025↗ | Connaughton Bernadette | Director | Sell | 2,000 | $68.48 | $137.0K | 42,952 |
| Nov 12, 2025↗ | Torley Helen | PRESIDENT AND CEO | Sell | 60,000 | $69.47 | $4.17M | 749,219 |
| Oct 3, 2025↗ | Torley Helen | PRESIDENT AND CEO | Sell | 60,000 | $71.86 | $4.31M | 747,119 |
| Oct 1, 2025↗ | Connaughton Bernadette | Sell | 2,000 | $75.24 | $150.5K | 45,452 | |
| Sep 23, 2025↗ | LaBrosse Nicole | SVP, CHIEF FINANCIAL OFFICER | Sell | 2,227 | $77.95 | $173.6K | 22,393 |
| Sep 11, 2025↗ | LaBrosse Nicole | SVP, CHIEF FINANCIAL OFFICER | Sell | 20,000 | $75.71 | $1.51M | 37,546 |
| Sep 4, 2025↗ | Torley Helen | PRESIDENT AND CEO | Sell | 60,000 | $74.08 | $4.44M | 753,419 |
| Sep 2, 2025↗ | Connaughton Bernadette | Sell | 4,000 | $73.68 | $294.7K | 50,852 | |
| Aug 13, 2025↗ | Torley Helen | PRESIDENT AND CEO | Sell | 60,000 | $63.62 | $3.82M | 740,677 |
| Jul 10, 2025↗ | Torley Helen | PRESIDENT AND CEO | Sell | 60,000 | $56.46 | $3.39M | 750,121 |
| Jun 24, 2025↗ | Torley Helen | PRESIDENT AND CEO | Sell | 60,000 | $53.09 | $3.19M | 749,230 |
| Apr 28, 2025↗ | Henderson Jeffrey William | Sell | 4,497 | $60.37 | $271.5K | 28,811 | |
| Apr 1, 2025↗ | Henderson Jeffrey William | Sell | 503 | $64.05 | $32.2K | 33,108 | |
| Mar 3, 2025↗ | Henderson Jeffrey William | Sell | 5,000 | $58.69 | $293.5K | 36,816 | |
| Feb 27, 2025↗ | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Sell | 21,697 | $58.10 | $1.26M | 186,153 |
| Feb 4, 2025↗ | Henderson Jeffrey William | Sell | 5,000 | $56.30 | $281.5K | 42,511 | |
| Jan 7, 2025↗ | Henderson Jeffrey William | Sell | 10,000 | $50.01 | $500.1K | 43,611 | |
| Oct 16, 2024↗ | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Sell | 20,000 | $53.50 | $1.07M | 173,833 |
| Oct 9, 2024↗ | Torley Helen | PRESIDENT AND CEO | Sell | 20,000 | $53.29 | $1.07M | 680,763 |
| Sep 26, 2024↗ | Torley Helen | PRESIDENT AND CEO | Sell | 30,000 | $56.88 | $1.71M | 676,744 |
| Sep 18, 2024↗ | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Sell | 20,000 | $62.46 | $1.25M | 175,793 |
| Sep 12, 2024↗ | Torley Helen | PRESIDENT AND CEO | Sell | 30,000 | $59.13 | $1.77M | 676,744 |
| Aug 21, 2024↗ | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Sell | 20,000 | $61.40 | $1.23M | 168,276 |
| Aug 15, 2024↗ | Torley Helen | PRESIDENT AND CEO | Sell | 30,000 | $57.15 | $1.71M | 683,481 |
| Aug 14, 2024↗ | Posard Matthew L. | Sell | 29,881 | $56.53 | $1.69M | 89,755 | |
| Jul 24, 2024↗ | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Sell | 20,000 | $55.00 | $1.10M | 173,467 |
| Jul 23, 2024↗ | LaBrosse Nicole | SVP, CHIEF FINANCIAL OFFICER | Sell | 5,000 | $53.93 | $269.7K | 15,480 |
| Jun 28, 2024↗ | LaBrosse Nicole | SVP, CHIEF FINANCIAL OFFICER | Sell | 30,000 | $51.93 | $1.56M | 15,480 |
| Jun 20, 2024↗ | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Sell | 10,000 | $49.43 | $494.3K | 168,176 |
| Jun 13, 2024↗ | Posard Matthew L. | Sell | 20,000 | $50.32 | $1.01M | 109,755 | |
| May 22, 2024↗ | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Sell | 20,000 | $45.27 | $905.5K | 168,176 |
| Apr 17, 2024↗ | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Sell | 20,000 | $38.42 | $768.4K | 168,176 |
| Mar 13, 2024↗ | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Sell | 20,000 | $41.96 | $839.1K | 156,558 |
| Feb 28, 2024↗ | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Sell | 20,000 | $39.75 | $794.9K | 159,087 |
| Jan 18, 2024↗ | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Sell | 20,000 | $36.00 | $720.0K | 151,911 |
| Dec 13, 2023↗ | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Sell | 20,000 | $40.01 | $800.3K | 152,554 |
| Nov 16, 2023↗ | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Sell | 20,000 | $39.43 | $788.7K | 151,911 |
| Oct 17, 2023↗ | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Sell | 10,000 | $36.52 | $365.2K | 151,911 |
| Sep 19, 2023↗ | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Sell | 10,000 | $39.10 | $391.0K | 151,911 |
| Aug 31, 2023↗ | Torley Helen | PRESIDENT AND CEO | Sell | 30,000 | $42.69 | $1.28M | 623,666 |
| Aug 23, 2023↗ | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Sell | 10,000 | $42.41 | $424.1K | 151,911 |
HALO Insiders
Similar Stocks to HALO
VRTX
Vertex Pharmaceuticals Incorporated
$470.20-1.66%
$121.44B
REGN
Regeneron Pharmaceuticals, Inc.
$743.51-0.41%
$77.57B
ALNY
Alnylam Pharmaceuticals, Inc.
$313.45-1.19%
$42.07B
INSM
Insmed Incorporated
$139.06-0.33%
$30.07B
UTHR
United Therapeutics Corporation
$536.12+0.97%
$23.50B
MRNA
Moderna, Inc.
$52.56-1.89%
$20.76B
ROIV
Roivant Sciences Ltd.
$28.06-1.44%
$20.08B
RPRX
Royalty Pharma plc
$45.65-0.57%
$19.56B